---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-103726"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:42:17.980055+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MindMed reports preliminary cash ~$209.1M as of Sep 30, 2025

## Summary
- Preliminary cash, cash equivalents and investments total approximately $209.1M as of September 30, 2025.
- Data is unaudited and subject to KPMG review; may differ from final Q3 figures.
- Filed a prospectus supplement and posted an updated corporate presentation on October 29, 2025.

## SEC filing metadata
- accession: 0001104659-25-103726
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/0001104659-25-103726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/tm2529652d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-103726
- JSON: https://secwatch.observer/filing/0001104659-25-103726.json
- Plain text: https://secwatch.observer/filing/0001104659-25-103726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.